Open AccessPrecision Oncology Comes of Age: Tumor-Agnostic Approaches
Author(s) -
Colleen Lewis,
R. Donald Harvey
Publication year - 2020
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2020.11.3.2
Subject(s) - medicine , microsatellite instability , precision medicine , cancer research , bioinformatics , oncology , medical physics , computational biology , pathology , microsatellite , genetics , biology , allele , gene
Colleen Lewis, MSN, ANP-BC, AOCNP®, and R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, presented on the new world of tumor-agnostic treatment approaches, including those aimed at managing patients with tumors that have high microsatellite instability (MSI-H) or neurotrophic receptor tyrosine kinase (NTRK) fusions. Learn about the clinical trial designs that enable development of these novel therapies, and discover how testing methodologies support precision medicine advances.